Month: February 2007
-
By Mark Chael — The National Collegiate Inventors & Innovators Alliance (NCIIA) co-produces the Invention to Venture (I2V) Workshop in association with various universities across the country throughout the year. Upcoming I2V Workshops in February and March will be held at the University of Illinois at Urbana-Champaign, Valparaiso University, the University of Portland,…
-
By Sherri Oslick On February 12, 2007 the House of Representatives passed bill H.R. 34, designed to "encourage enhancement of expertise in patent cases among district judges." The bill establishes a pilot program in certain district courts providing the judges of those districts with the opportunity to decline to hear patent cases. Under the…
-
By Kevin Noonan Michael Crichton has always hated – or feared – technology. In his novels The Andromeda Strain, The Terminal Man, and Jurassic Park, he has been a technology Cassandra, a modern-day Luddite warning that technology would get us if we weren’t very careful. And while space viruses, inhuman cyborgs, and thunder…
-
By Jason Derry Reportlinker has announced the availability of a new report that covers strategies and information relating to creating successful licensing deals in the biotechnology industry. The report, "Biopartnering Strategies: Maximizing returns from biotechnology deal-making," covers topics such as in-licensing and out-licensing biotechnologies, as well as biopartnering trends and strategies. In addition,…
-
February 14, 2007 – "MedImmune v. Genentech: Impact of the Supreme Court's Jan. 9 Decision on Patent Licenses" Teleconference (Strafford CLE Teleconferences) February 16, 2007 – Patent Claim Construction Conference (Law Seminars International) – Chicago, IL February 20, 2007 – "Potential Licensing Responses to MedImmune: The Supreme Court's Latest Word on Declaratory Judgment Actions Challenging…
-
By Donald Zuhn The Biotechnology Industry Organization (BIO) will be holding its annual BIO International Convention on May 6-9, 2007 in Boston, MA. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,100 biotechnology companies, state and international affiliates, and related organizations, as well as…
-
By Kevin Noonan On first blush, it might appear that Indonesia’s decision to stop supplying avian influenza virus samples to global public health organizations, such as the U.N’s World Health Organization (WHO), is short-sighted or greedy or both (see "Virus for Sale"). However, the "rest of the story," at least in part, is…
-
By Christopher P. Singer In a February 9, 2007 press release, Sanofi-Aventis announced that it has lost its patent infringement suit against generic drugmakers Amphastar Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd., filed in the U.S. District Court for the Central District of California. The suit relates to Sanofi-Aventis’ blockbuster blood thinning drug,…
-
By Kevin Noonan Indonesia is a country of over 200 million encompassing more than 17,000 islands in the Malay archipelago. It also has the largest number (81) of humans infected with the H5N1 strain of influenza virus (commonly called "bird flu"), with 63 fatalities. And until recently, it was a principle source of…
-
Law Seminars International's second annual conference on Patent Claim Construction will be held on February 16, 2007 in Chicago, Illinois. The conference, entitled "New Developments in Patent Claim Construction," will focus on current case law updates, patent litigation strategies, effective advocacy tactics for presenting Markman Hearing cases, choosing and working with outside counsel, and handling…
Patent Docs 